{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:19:35Z","timestamp":1790957975829,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/ 10\/FR\/81\/2020-RBMCH"],"award-info":[{"award-number":["5\/ 10\/FR\/81\/2020-RBMCH"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.cyto.2024.156639","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T05:34:55Z","timestamp":1715319295000},"page":"156639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Apelin receptor modulation mitigates letrozole-induced polycystic ovarian pathogenesis in mice"],"prefix":"10.1016","volume":"179","author":[{"given":"Borgohain","family":"Anima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guruswami","family":"Gurusubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas Kumar","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2024.156639_b0005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/humupd\/dmn015","article-title":"Follicle dynamics and anovulation in polycystic ovary syndrome","volume":"14","author":"Franks","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.cyto.2024.156639_b0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000485995","article-title":"Metabolic syndrome in polycystic ovary syndrome","volume":"49","author":"Pasquali","year":"2018","journal-title":"Front Horm Res"},{"key":"10.1016\/j.cyto.2024.156639_b0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/er.2004-0004","article-title":"The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome","volume":"26","author":"Escobar-Morreale","year":"2005","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cyto.2024.156639_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1740001","article-title":"Developmental origin of polycystic ovary syndrome - a hypothesis","volume":"174","author":"Abbott","year":"2002","journal-title":"J Endocrinol"},{"key":"10.1016\/j.cyto.2024.156639_b0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat. Rev. Endocrinol"},{"key":"10.1016\/j.cyto.2024.156639_b0030","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1210\/en.2014-1196","article-title":"Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models","volume":"155","author":"Caldwell","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.cyto.2024.156639_b0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2013.01.013","article-title":"Nonhuman primate models of polycystic ovary syndrome","volume":"373","author":"Abbott","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.cyto.2024.156639_b0040","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/en.2012-1366","article-title":"Animal models and the developmental origins of polycystic ovary syndrome: increasing evidence for the role of androgens in programming reproductive and metabolic dysfunction","volume":"153","author":"Franks","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.cyto.2024.156639_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119409","article-title":"Inhibition of visfatin by FK866 mitigates pathogenesis of cystic ovary in letrozole-induced hyperandrogenised mice","volume":"276","author":"Annie","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.cyto.2024.156639_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1070264","article-title":"Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis","volume":"14","author":"Peng","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cyto.2024.156639_b0055","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0015-0282(02)03241-7","article-title":"A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women","volume":"78","author":"Fisher","year":"2002","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cyto.2024.156639_b0060","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.arcmed.2006.04.006","article-title":"Microscopic characterization of follicular structures in letrozole-induced polycystic ovarian syndrome in the rat","volume":"37","author":"Baravalle","year":"2006","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.cyto.2024.156639_b0065","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1210\/en.2007-0168","article-title":"A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome","volume":"148","author":"Manner\u00e5s","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.cyto.2024.156639_b0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.arcmed.2003.10.005","article-title":"Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease","volume":"35","author":"Kafali","year":"2004","journal-title":"Arch. Med. Res"},{"key":"10.1016\/j.cyto.2024.156639_b0075","doi-asserted-by":"crossref","first-page":"E765","DOI":"10.1210\/jc.2011-2377","article-title":"Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome","volume":"97","author":"Chazenbalk","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cyto.2024.156639_b0080","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4161\/adip.28731","article-title":"Gene expression in subcutaneous adipose tissue differs in women with polycystic ovary syndrome and controls matched pair-wise for age, body weight, and body mass index","volume":"3","author":"Manner\u00e5s-Holm","year":"2014","journal-title":"Adipocyte"},{"key":"10.1016\/j.cyto.2024.156639_b0085","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/cen.12120","article-title":"Circulating apelin level in relation to nutritional status in polycystic ovary syndrome and its association with metabolic and hormonal disturbances","volume":"79","author":"Olszanecka-Glinianowicz","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cyto.2024.156639_b0090","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.mefs.2018.04.003","article-title":"Serum adipokine (apelin) in lean and obese polycystic ovary syndrome patients before and after metformin treatment","volume":"23","author":"Hasan","year":"2018","journal-title":"Middle East Fertil. Soc. J."},{"key":"10.1016\/j.cyto.2024.156639_b0095","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.12659\/MSM.894926","article-title":"Evaluation of apelin and insulin resistance in patients with PCOS and therapeutic effect of drospirenone-ethinyl estradiol plus metformin","volume":"21","author":"Sun","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.cyto.2024.156639_b0100","doi-asserted-by":"crossref","first-page":"S635","DOI":"10.33549\/physiolres.934708","article-title":"Is Apelin a new biomarker in patients with polycystic ovary syndrome?","volume":"70","author":"Draveck\u00e1","year":"2021","journal-title":"Physiol. Res."},{"key":"10.1016\/j.cyto.2024.156639_b0105","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.cyto.2024.156639_b0110","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0378-1119(93)90495-O","article-title":"A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11","volume":"136","author":"O'Dowd","year":"1993","journal-title":"Gene"},{"key":"10.1016\/j.cyto.2024.156639_b0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1095\/biolreprod.116.141754","article-title":"Apelin (APLN) and Apelin Receptor (APLNR) in human ovary: expression, signaling, and regulation of steroidogenesis in primary human luteinized granulosa cells","volume":"95","author":"Roche","year":"2016","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.cyto.2024.156639_b0120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cca.2019.09.011","article-title":"Role of apelin\/APJ system in hypothalamic-pituitary axis","volume":"499","author":"Yang","year":"2019","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.cyto.2024.156639_b0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mrd.23657","article-title":"Postnatal developmental expression and localization of apelin and apelin receptor protein in the ovary and uterus of mice","volume":"90","author":"Anima","year":"2023","journal-title":"Mol. Reprod. Dev. Mol Reprod Dev"},{"key":"10.1016\/j.cyto.2024.156639_b0130","doi-asserted-by":"crossref","unstructured":"B. Anima, G. Guruswami, V.K. Roy, Expression of apelin and apelin receptor protein in the hypothalamo-pituitary-ovarian axis during estrous cycle of mice, Neuroendocrinology, 10.1159 (2023) 000534838. Advance online publication. DOI: 10.1159\/000534838.","DOI":"10.1159\/000534838"},{"key":"10.1016\/j.cyto.2024.156639_b0135","first-page":"27","article-title":"Plasma apelin levels in patients with polycystic ovary syndrome","volume":"13","author":"G\u00f6ren","year":"2012","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"10.1016\/j.cyto.2024.156639_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118310","article-title":"Apelin\/apelin receptor: a new therapeutic target in polycystic ovary syndrome","volume":"260","author":"Liu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.cyto.2024.156639_b0145","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.steroids.2012.08.005","article-title":"Serum asymmetric dimethylarginine, apelin, and tumor necrosis factor-\u03b1 levels in non-obese women with polycystic ovary syndrome","volume":"77","author":"Choi","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.cyto.2024.156639_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2011.04.044","article-title":"Lower serum apelin levels in women with polycystic ovary syndrome","volume":"95","author":"Chang","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cyto.2024.156639_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155554","article-title":"Expression and localization of apelin and its receptor in the testes of diabetic mice and its possible role in steroidogenesis","volume":"144","author":"Das","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2024.156639_b0160","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12265-022-10214-3","article-title":"MicroRNA-122-5p Aggravates Angiotensin II-Mediated Myocardial Fibrosis and Dysfunction in Hypertensive Rats by Regulating the Elabela\/Apelin-APJ and ACE2-GDF15-Porimin Signaling","volume":"15","author":"Song","year":"2022","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.cyto.2024.156639_b0165","first-page":"319","article-title":"The analgesic effect of apelin-13 and its mechanism of action within the nitric oxide and serotonin pathways","volume":"19","author":"Turtay","year":"2015","journal-title":"Hippokratia"},{"key":"10.1016\/j.cyto.2024.156639_b0170","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.canlet.2016.11.025","article-title":"Inhibition of the apelin\/apelin receptor axis decreases cholangiocarcinoma growth","volume":"386","author":"Hall","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cyto.2024.156639_b0175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.reprotox.2022.12.001","article-title":"Oxidative stress in the ovaries of mice chronically exposed to a low lead concentration: A generational approach","volume":"115","author":"Trujillo-V\u00e1zquez","year":"2023","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.cyto.2024.156639_b0180","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.cyto.2024.156639_b0185","first-page":"8140","article-title":"Anti oxidant role of elevated apelin","volume":"6","author":"Diab","year":"2014","journal-title":"Int. J. Curr. Res."},{"key":"10.1016\/j.cyto.2024.156639_b0190","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.3390\/ijms20153778","article-title":"Ovarian expression of adipokines in polycystic ovary syndrome: a role for chemerin, omentin, and apelin in follicular growth arrest and ovulatory dysfunction?","volume":"20","author":"Bongrani","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2024.156639_b0195","doi-asserted-by":"crossref","first-page":"9921","DOI":"10.1038\/s41598-020-64257-0","article-title":"Core binding factors are essential for ovulation, luteinization, and female fertility in mice","volume":"10","author":"Lee-Thacker","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2024.156639_b0200","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1210\/en.2011-1754","article-title":"Reproductive and metabolic phenotype of a mouse model of PCOS","volume":"153","author":"van Houten","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.cyto.2024.156639_b0205","doi-asserted-by":"crossref","unstructured":"J. Yeh, H.H. Kim, Polycystic ovary syndrome (PCOS): the possible roles of apoptosis in human granulosa cells, Polycystic ovary syndrome (pp. 51-70). (1996). DOIDOI: 10.1007\/978-1-4613-8483-0_4.","DOI":"10.1007\/978-1-4613-8483-0_4"},{"key":"10.1016\/j.cyto.2024.156639_b0210","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1071\/RD17255","article-title":"Systemic adiponectin treatment reverses polycystic ovary syndrome-like features in an animal model","volume":"30","author":"Singh","year":"2018","journal-title":"Reprod. Fertil. Dev."},{"key":"10.1016\/j.cyto.2024.156639_b0215","first-page":"565","article-title":"Apoptosis as a basic mechanism in the ovarian cycle: follicular atresia and luteal regression","volume":"2","author":"Palumbo","year":"1995","journal-title":"J. Soc. Gynecol. Investig."},{"key":"10.1016\/j.cyto.2024.156639_b0220","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.4103\/1673-5374.300725","article-title":"Apelin-13 inhibits apoptosis and excessive autophagy in cerebral ischemia\/reperfusion injury","volume":"16","author":"Shao","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.cyto.2024.156639_b0225","doi-asserted-by":"crossref","first-page":"409","DOI":"10.12891\/ceog2133.2016","article-title":"Effects of apelin on proliferation and apoptosis in rat ovarian granulosa cells","volume":"43","author":"Shuang","year":"2016","journal-title":"Clin. Exp. Obstet. Gynecol"},{"key":"10.1016\/j.cyto.2024.156639_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2022.106178","article-title":"Postnatal developmental expression of apelin receptor proteins and its role in juvenile mice testis","volume":"224","author":"Das","year":"2022","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cyto.2024.156639_b0235","doi-asserted-by":"crossref","first-page":"14126","DOI":"10.3390\/ijms241814126","article-title":"Polycystic ovary syndrome and oxidative stress-from bench to bedside","volume":"24","author":"Zeber-Lubecka","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2024.156639_b0240","doi-asserted-by":"crossref","first-page":"2253347","DOI":"10.1080\/14767058.2023.2253347","article-title":"Interleukin-22 promotes proliferation and reverses LPS-induced apoptosis and steroidogenesis attenuation in human ovarian granulosa cells: implications for polycystic ovary syndrome pathogenesis","volume":"36","author":"Liu","year":"2023","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.cyto.2024.156639_b0245","first-page":"643","article-title":"Circulating levels of apoptotic markers and oxidative stress parameters in women with polycystic ovary syndrome: a case-controlled descriptive study","volume":"22","author":"Uyanikoglu","year":"2017","journal-title":"Biomarkers"},{"key":"10.1016\/j.cyto.2024.156639_b0250","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s11259-023-10107-z","article-title":"The effects of apelin on IGF1\/FSH-induced steroidogenesis, proliferation, Bax expression, and total antioxidant capacity in granulosa cells of buffalo ovarian follicles","volume":"47","author":"Shokrollahi","year":"2023","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.cyto.2024.156639_b0255","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1139\/cjpp-2021-0337","article-title":"The protective effect of apelin-13 on cardiorenal toxicity induced by cyclophosphamide","volume":"100","author":"Kutlay","year":"2022","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.cyto.2024.156639_b0260","doi-asserted-by":"crossref","first-page":"1017468","DOI":"10.3389\/fendo.2022.1017468","article-title":"A review of the hormones involved in the endocrine dysfunctions of polycystic ovary syndrome and their interactions","volume":"13","author":"Emanuel","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cyto.2024.156639_b0265","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1530\/REP-16-0677","article-title":"Apelin (APLN) regulates progesterone secretion and oocyte maturation in bovine ovarian cells","volume":"153","author":"Roche","year":"2017","journal-title":"Reproduction (Cambridge, England)"},{"key":"10.1016\/j.cyto.2024.156639_b0270","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3390\/cells10020459","article-title":"Estrogen receptors in polycystic ovary syndrome","volume":"10","author":"Xu","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cyto.2024.156639_b0275","first-page":"829","article-title":"Androgen receptor coregulator CTBP1-AS is associated with polycystic ovary syndrome in chinese women: a preliminary study","volume":"22","author":"Liu","year":"2015","journal-title":"ReprodSci"},{"key":"10.1016\/j.cyto.2024.156639_b0280","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.gendis.2019.09.005","article-title":"SRSFs mediate the function of AR in the ovarian granulosa cells of patients with PCOS","volume":"8","author":"Luo","year":"2019","journal-title":"Genes Dis."},{"key":"10.1016\/j.cyto.2024.156639_b0285","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/BF03350785","article-title":"Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome","volume":"21","author":"Hall","year":"1998","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.cyto.2024.156639_b0290","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.fertnstert.2006.05.001","article-title":"Gonadotropin dysfunction in women with polycystic ovary syndrome","volume":"86","author":"Taylor","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cyto.2024.156639_b0295","unstructured":"R.L. Barbieri, D.A. Ehrmann, Patient education: Polycystic ovary syndrome (PCOS)(Beyond the Basics), (2018) Up To Date. http:\/\/www. uptodate. com\/(uppdaterat:[03.03 2020])."},{"key":"10.1016\/j.cyto.2024.156639_b0300","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.toxrep.2022.10.009","article-title":"Gallic acid reverses ovarian disturbances in mice with letrozole-induced PCOS via modulating Adipo R1 expression","volume":"9","author":"UlHaq Shah","year":"2022","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.cyto.2024.156639_b0305","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/rmb2.12262","article-title":"Animal models of polycystic ovary syndrome: A review of hormone-induced rodent models focused on hypothalamus-pituitary-ovary axis and neuropeptides","volume":"18","author":"Osuka","year":"2019","journal-title":"Reprod Med. Biol."},{"key":"10.1016\/j.cyto.2024.156639_b0310","first-page":"9170480","article-title":"Apelin in reproductive physiology and pathology of different species: a critical review","author":"Kurowska","year":"2018","journal-title":"Int J. Endocrinol."},{"key":"10.1016\/j.cyto.2024.156639_b0315","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1139\/bcb-2014-0072","article-title":"The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR","volume":"92","author":"Chapman","year":"2014","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.cyto.2024.156639_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101629","article-title":"Individual phosphorylation sites at the C-terminus of the apelin receptor play different roles in signal transduction","volume":"36","author":"Chen","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.cyto.2024.156639_b0325","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0021-9258(19)69862-5","article-title":"On the mechanism of ligand-induced down-regulation of insulin receptor level in the liver cell","volume":"256","author":"Krupp","year":"1981","journal-title":"J. Biol. Chem."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662400142X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662400142X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T22:01:43Z","timestamp":1718748103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346662400142X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":65,"alternative-id":["S104346662400142X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156639","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apelin receptor modulation mitigates letrozole-induced polycystic ovarian pathogenesis in mice","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156639","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156639"}}